Miltenyi Biomedicine
Pharmaceutical Manufacturing • 
Bergisch Gladbach, North Rhine-Westphalia, Germany • 101-200 Employees
Company overview
| Headquarters | Friedrich-Ebert Straße 68, Bergisch Gladbach, North Rhine-Westphalia 51429, DE |
| Phone number | +4922048306820 |
| Websites | |
| NAICS | 3254 |
| Keywords | Gene Therapy, Research, Biopharma, Clinical Trials, Clinical Development, Innovation, Immunotherapy, Cancer Research, Immunology, Clinical Applications, Stem Cell Research, Cell Therapy, Hematological Cancers, Car-T Cells, Innovative Therapies, Autologous T Cells, Car-T Technology, Fresh Cells Approach, Optimizing Patient Outcomes, Personalized Cell And Gene Therapies |
| Founded | 2019 |
| Employees | 101-200 |
| Socials |
Key Contacts at Miltenyi Biomedicine
Hilary Hall
Executive Director Marketing, Us
Michael Terhoeven
Global Director Supply Chain And Pmo @ Miltenyi Biomedicine
Meghan Monzon
Director Cell Therapy Business Excellence
Vicente Godoy
Director Global Clinical Qa
Sandra Kotnyek
Global Digital Ecosystem Director
Jessica Foglesong
Clinical Development Medical Director
Ron Gomez
Director Clinical Operations
Sara Cole
Executive Director, Cell Therapy Business Excellence
Marek Ancukiewicz
Senior Director, Head Of Biostatistics, North America
Jasmine Oberwalleney
Apac Car-T Launch Director
Miltenyi Biomedicine Email Formats
Miltenyi Biomedicine uses 5 email formats. The most common is {first name}.{last name} (e.g., john.doe@miltenyibiomedicine.com), used 53.2% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@miltenyibiomedicine.com | 53.2% |
{first initial}.{last name} | j.doe@miltenyibiomedicine.com | 41.8% |
{first initial}{last name} | jdoe@miltenyibiomedicine.com | 2.5% |
{first initial} | j@miltenyibiomedicine.com | 1.3% |
{last name}.{first initial} | doe.j@miltenyibiomedicine.com | 1.3% |
About Miltenyi Biomedicine
Miltenyi Biomedicine is a biopharmaceutical company that develops innovative cell and gene therapies. We are committed to bring cancer treatments and regenerative therapies to patients with unmet medical needs worldwide. We work in partnership with physicians and other healthcare providers to expand access to new therapies. Our clinical research program includes: CAR T, CAR NK, our proprietary Adapter CAR™ and induced pluripotent stem cells (iPSC) technologies. For more information, please visit our website at www.miltenyibiomedicine.com.
Miltenyi Biomedicine revenue & valuation
| Annual revenue | $13,600,000 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $43,300,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 101-200
Seniority
Employees
Employees by Department
Miltenyi Biomedicine has 96 employees across 10 departments.
Departments
Number of employees
Funding Data
Miltenyi Biomedicine has never raised funding before.
Miltenyi Biomedicine Tech Stack
Discover the technologies and tools that power Miltenyi Biomedicine's digital infrastructure, from frameworks to analytics platforms.
CDN
Font scripts
Cookie compliance
Miscellaneous
Security
Miscellaneous
JavaScript frameworks
Miscellaneous
JavaScript frameworks
JavaScript libraries
United Kingdom
Saudi Arabia
Frequently asked questions
4.8
40,000 users
